Gibbs Cancer Center and Research Institute

Spartanburg, South Carolina 29303

1 studies enrolling now · 4 studies all time

What they study most

Advanced Melanoma, Leukemia, Promyelocytic, Acute, Metastatic Pancreas Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer

Studies at this site

• Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) — Recruiting now
• Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer — Completed
• Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer — Completed
• Impact of a Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL) by Maintaining a Database — Stopped early